Are surrogate markers of intestinal inflammation predictive of relapse in patients with inflammatory bowel disease?
Fecal calprotectin predicts clinical relapse of disease activity in patients with CD and UC, whereas small intestinal permeability is a useful predictor of relapse in patients with small intestinal CD.
TNF inhibition after infarction reduced leukocyte infiltration and extracellular matrix turnover and preserved cardiac function.